Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Wordle 1792 Hints and Answer Sustained Engagement Drives NYTs Digital Subscription Growth Exicure XCUR Declines 1069 Amid Market Weakness 20260515 Under Armour CEO Kevin Plank Defends Micromanagement Citing Steve Jobs and Elon Musk as Kindred Spirits Chenel Capital Partners Richard Chenel Discusses Space Industry Maturation Ahead of Summit Canterbury CPHC at 1590 Buy Sell or Hold 20260518 Datacentrex DTCX Stock Slides 087 Support at 216 20260515 IKEA Franchisor Implements Significant Job Cuts Amid Global Restructuring Quantum QNTM Stock Slides 117 Support at 639 20260518 Este Lauder Abandons Merger Talks with Spanish Beauty Rival Puig Boston Scientific Shares Decline After Reiterating FullYear Growth Outlook ura Health Files for IPO Smart Ring Maker Seeks Public Listing Solaris Energy Infrastructure Completes Nearly 2 Billion Financing to Fuel Expansion Taiwans Geopolitical Stance Emerges as a Key Unspoken Factor in TrumpXi Talks Dow Jones Futures Steady as Trump Hints at Iran Deal Tesla and AI Stocks Approach Potential Buy Points South Bow Corporation SOBO Q1 2026 Earnings EPS Misses Estimates by 37 Amid Challenging Quarter Stock Rises Marginally CLDX Q1 2026 Earnings Clinicalstage biotech reports widerthanexpected loss as pipeline investment continues ANTA Q1 2026 Earnings Significant EPS Miss Raises Concerns CFR Q1 2026 Earnings Earnings Beat Driven by Strong Core Performance Universal Technical Institute Inc UTI Q1 2026 Earnings EPS Misses Estimates Amid Mixed Signals Stock Surges RVMD Q1 2026 Earnings EPS Miss Reflects Increased RD Spending Pipeline Progress Continues Paysafe PSFE Shows Resilience Uptrend Challenges Key Resistance at 818 Adagene ADAG Slips 106 as Stock Tests Key Support Near 356 MiniMed Group Inc MMED Slips 282 as Shares Approach Key Support Threshold ACM Research ACMR Gains 25 as Stock Approaches Key Resistance Level Palvella Therapeutics PVLA Gains Mildly as It Approaches Key Resistance